Global Non-Viral Drug Delivery Systems Markets, 2021-2030: Focus on Intracellular Technologies and Intracellular Biologics - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Viral Drug Delivery Systems (Focus on Intracellular Technologies and Intracellular Biologics) Market by Type of Molecule and Key Geographies: Industry Trends and Global Forecasts 2021-2030" report has been added to ResearchAndMarkets.com's offering.

The "Non-Viral Drug Delivery Systems: Focus on Intracellular Technologies and Intracellular Biologics Market, 2021-2030" report features an extensive study of the current landscape and the likely future opportunities in intracellular drug delivery technologies market for the next 10 years.

One of the key objectives of the report was to estimate the existing market size and identify potential future growth opportunities for intracellular drug delivery technologies. Based on likely licensing deal structures and agreements that are expected to be signed in the foreseen future, we have provided an informed estimate on the evolution of the market over the period 2021-2030.

The report features likely distribution of the current and forecasted opportunity across the [A] type of molecule delivered (DNA, RNA, small molecule and others), and [B] key geographical regions (North America, Europe, Asia Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.

Amongst other elements, the report includes:

• A detailed review of the overall landscape of the intracellular drug delivery technologies, featuring an in-depth analysis based on a number of parameters, such as type of molecule delivered, type of biologic delivered, type of bond between the vehicle and the payload, type of vehicle used, and availability of intellectual property. In addition, the chapter features a list of technology developers and a detailed analysis based on year of establishment, company size and geographical location.
• A detailed competitiveness analysis of intracellular drug delivery technologies, taking into consideration the supplier power (based on the year of establishment of the developer) and key technology specifications, such as availability of intellectual property, number of deals signed during 2015 - 2020, number of products / programs developed based on technologies and type of molecule(s) delivered (biologics / small molecules).
• An in-depth analysis of the patents filed for intracellular drug delivery technologies based on various relevant parameters, such as publication year, geographical location, issuing authority, assigned CPC symbol, highlighting the emerging focus areas and leading industry / academic players (in terms of size of intellectual property portfolio). It also includes a patent benchmarking analysis and a detailed valuation analysis.
• An analysis of the partnerships that have been established in the recent past, covering R&D collaborations, licensing agreements (specific to technology platforms), product development and commercialization agreements, manufacturing agreements, mergers and acquisitions, and other relevant agreements.
• Elaborate profiles of prominent technology developers engaged in this domain. Each profile features a brief overview of the company, its financial information (if available), information on its technology portfolio, recent developments and an informed future outlook.
• A case study on the molecules developed / being developed using the intracellular drug delivery technology with analysis based on the phase of development, type of molecule and the target disease indication.

Key Topics Covered:

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview

3.2. Challenges Associated with Intracellular Delivery of Biologics

3.3. Need for Targeted Drug Delivery

3.4. Intracellular Drug Delivery Approaches

3.5. Future of Intracellular Drug Delivery

4. MARKET LANDSCAPE

4.1. Chapter Overview

4.2. Intracellular Drug Delivery Technologies: List of Technologies

4.3. Intracellular Drug Delivery Technologies: List of Technology Developers

4.4. Intracellular Drug Delivery: List of Other Technologies

5. TECHNOLOGY COMPETITIVENESS ANALYSIS

5.1. Chapter Overview

5.2. Methodology

5.3. Assumptions / Key Parameters

5.4. Technology Competitiveness Analysis: Intracellular Drug Delivery Technologies

6. COMPANY PROFILES

6.1. Chapter Overview

6.2. Arcturus Therapeutics

6.2.1. Company Overview

6.2.2. Technology Portfolio

6.2.3. Recent Developments and Future Outlook

6.3. Bio-Path Holdings

6.4. CureVac

6.5. Entos Pharmaceuticals

6.6. eTheRNA immunotherapies

6.7. PCI Biotech

7. PATENT ANALYSIS

7.1. Chapter Overview

7.2. Scope and Methodology

7.3. Intracellular Drug Delivery Technologies: Patent Analysis

7.4. Intracellular Drug Delivery Technologies: Patent Benchmarking Analysis

8. PARTNERSHIPS AND COLLABORATIONS

8.1. Chapter Overview

8.2. Partnership Models

8.3. Intracellular Drug Delivery Technologies: List of Partnerships and Collaborations

9. CASE STUDY: INTRACELLULAR THERAPIES

9.1. Chapter Overview

9.2. Intracellular Therapies: Pipeline Review

10. MARKET FORECAST AND OPPORTUNITY ANALYSIS

10.1. Chapter Overview

10.2. Key Assumptions

10.3. Forecast Methodology

10.4. Global Intracellular Drug Delivery Technologies Market, 2021-2030

10.5. Intracellular Drug Delivery Technologies Market: Distribution by Type of Molecule, 2021-2030

10.6. Intracellular Drug Delivery Technologies Market: Distribution by Region, 2021-2030

11. CONCLUDING REMARKS

11.1. Chapter Overview

11.2. Key Takeaways

12. EXECUTIVE INSIGHTS

12.1. Chapter Overview

12.2. Biond Biologics

12.3. PCI Biotech

12.4. SRI International

13. APPENDIX 1: TABULATED DATA

For more information about this report visit https://www.researchandmarkets.com/r/au4gbc